Literature DB >> 12698098

Outbreak of invasive aspergillosis among renal transplant recipients.

Anil A Panackal1, Andrea Dahlman, Katharina T Keil, Carol L Peterson, Laurene Mascola, Sara Mirza, Maureen Phelan, Brent A Lasker, Mary E Brandt, Joseph Carpenter, Michael Bell, David W Warnock, Rana A Hajjeh, Juliette Morgan.   

Abstract

Invasive aspergillosis (IA) is rare among renal transplant recipients (RTRs). We investigated a cluster of IA among RTRs at a California hospital from January to February 2001, when construction was ongoing. We conducted a cohort study among RTRs who were hospitalized between January 1 and February 5, 2001, to determine risk factors for IA. IA was defined using established guidelines. Four IA cases occurred among 40 RTRs hospitalized during the study period. Factors associated with an increased risk of IA included prolonged hemodialysis, lengthy corticosteroid treatment posttransplant, and use of sirolimus alone or with mycophenolate (P<0.05). After the study period, three additional RTRs developed IA; two Aspergillus isolates recovered from these patients had indistinguishable profiles by DNA fingerprinting, suggesting common-source exposure. This study suggests that immunosuppressed RTRs can be at an increased risk for IA. Measures to prevent IA in these patients should be taken during hospital construction.

Entities:  

Mesh:

Year:  2003        PMID: 12698098     DOI: 10.1097/01.TP.0000055983.69730.ED

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.

Authors:  Kelong Han; Robert Bies; Heather Johnson; Blair Capitano; Raman Venkataramanan
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

3.  Successful treatment of mucormycosis in a renal allograft recipient.

Authors:  Adel Bakr; Ehab Wafa; Ashraf Fouda; Amgad Elagroudy; Osama Gheith; Mohamed Sobh; Ahmed Shokeir; Mohamed Ghoneim
Journal:  Clin Exp Nephrol       Date:  2008-03-20       Impact factor: 2.801

Review 4.  Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Authors:  Judith A Anesi; John W Baddley
Journal:  Infect Dis Clin North Am       Date:  2015-12-28       Impact factor: 5.982

5.  Characterization of a novel gene for strain typing reveals substructuring of Aspergillus fumigatus across North America.

Authors:  S Arunmozhi Balajee; Sun T Tay; Brent A Lasker; Steve F Hurst; Alejandro P Rooney
Journal:  Eukaryot Cell       Date:  2007-06-08

Review 6.  Invasive fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham; Kieren A Marr
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

7.  Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals.

Authors:  S Arunmozhi Balajee; Molly Weaver; Alexander Imhof; Jennifer Gribskov; Kieren A Marr
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

8.  Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.

Authors:  Kelong Han; B Capitano; R Bies; B A Potoski; S Husain; S Gilbert; D L Paterson; K McCurry; R Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

9.  Voriconazole pharmacokinetics in liver transplant recipients.

Authors:  H J Johnson; Kelong Han; B Capitano; D Blisard; S Husain; P K Linden; A Marcos; E J Kwak; B Potoski; D L Paterson; M Romkes; R Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.